Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Lori E. Dodd"'
Autor:
Irini Sereti, Kathryn Shaw-Saliba, Lori E. Dodd, Robin L. Dewar, Sylvain Laverdure, Shawn Brown, Olivier Tshiani Mbaya, Jean Jacques Muyembe Tamfum, Placide Mblala-Kingebeni, Ydrissa Sow, Esther Akpa, Mory Cherif Haidara, Karine Fouth Tchos, Abdoul Habib Beavogui, Aaron Neal, Dona Arlinda, Dewi Lokida, Louis Grue, Mary Smolskis, Laura A. McNay, Dehkontee Gayedyu-Dennis, Guillermo M. Ruiz-Palacios, Abelardo Montenegro-Liendo, Moctar Tounkara, Seydou Samake, Ganbolor Jargalsaikhan, Delgersaikhan Zulkhuu, Shera Weyers, Tyler Bonnett, Gail E. Potter, Randy Stevens, Adam Rupert, Jamila Aboulhab, Jean-Luc Biampata, Alexandre Delamo, Bienvenu Salim Camara, Herman Kosasih Indonesia, Muhammad Karyana, James T. Duworko, Justino Regalado-Pineda, Paola del Carmen Guerra-de-Blas, Seydou Doumbia, Djeneba Dabitao, Naranjargal Dashdorj, Naranbaatar Dashdorj, Kevin Newell, Alyson Francis, Kevin Rubenstein, Victoria Bera, Iman Gulati, Ratna Sardana, Monica Millard, Renee Ridzon, Sally Hunsberger
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines b
Externí odkaz:
https://doaj.org/article/35221598c0804d42bd34c327097f7182
Autor:
Taeksun Song, Myungsun Lee, Han-Seung Jeon, Yumi Park, Lori E. Dodd, Véronique Dartois, Dean Follman, Jing Wang, Ying Cai, Lisa C. Goldfeder, Kenneth N. Olivier, Yingda Xie, Laura E. Via, Sang Nae Cho, Clifton E. Barry III, Ray Y. Chen
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1627-1633 (2015)
Long-term linezolid use is limited by mitochondrial toxicity-associated adverse events (AEs). Within a prospective, randomized controlled trial of linezolid to treat chronic extensively drug-resistant tuberculosis, we serially monitored the translati
Externí odkaz:
https://doaj.org/article/7beaa75555b04827aa0e2b13b0e0cec4
Autor:
Ray Y. Chen, Laura E. Via, Lori E. Dodd, Gerhard Walzl, Stephanus T. Malherbe, André G. Loxton, Rodney Dawson, Robert J. Wilkinson, Friedrich Thienemann, Michele Tameris, Mark Hatherill, Andreas H. Diacon, Xin Liu, Jin Xing, Xiaowei Jin, Zhenya Ma, Shouguo Pan, Guolong Zhang, Qian Gao, Qi Jiang, Hong Zhu, Lili Liang, Hongfei Duan, Taeksun Song, David Alland, Michael Tartakovsky, Alex Rosenthal, Christopher Whalen, Michael Duvenhage, Ying Cai, Lisa C. Goldfeder, Kriti Arora, Bronwyn Smith, Jill Winter, Clifton E. Barry III, Predict TB Study Group
Publikováno v:
Gates Open Research, Vol 1 (2017)
Background: By the early 1980s, tuberculosis treatment was shortened from 24 to 6 months, maintaining relapse rates of 1-2%. Subsequent trials attempting shorter durations have failed, with 4-month arms consistently having relapse rates of 15-20%. On
Externí odkaz:
https://doaj.org/article/2e9744f070dd42cc8f0373c77478494c
Autor:
Lori E. Dodd, Aneesh K. Mehta, Anuradha Ganesan, Susan McLellan, Jonathan Fintzi, Maria G. Frank, Pablo Tebas, Tyler Bonnett, Daniel A. Sweeney, Nikhil Huprikar
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how
Autor:
Constance A. Benson, Otto O. Yang, Sarah B Doernberg, Robert Grossberg, Jing Wang, David C. Lye, Philip O Ponce, Cameron R. Wolfe, Richard T. Davey, Shannon K. Gallagher, Lori E. Dodd, Jocelyn Voell, Rekha R. Rapaka, William R. Short, Noreen A. Hynes, Catharine I. Paules
Publikováno v:
Clinical Infectious Diseases. 74:1260-1264
This post hoc analysis of the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 (ACTT-1) shows a treatment effect of remdesivir (RDV) on progression to invasive mechanical ventilation (IMV) or death. Additionally, we create a risk profil
Autor:
Christopher J. Colombo, MD, MA, FACP, FCCM, Rhonda E. Colombo, MD, MHS, FACP, FIDSA, Ryan C. Maves, MD, FCCM, FCCP, FIDSA, Angela R. Branche, MD, Stuart H. Cohen, MD, Marie-Carmelle Elie, MD, Sarah L. George, MD, Hannah J. Jang, PhD, RN, CNL, PHN, Andre C. Kalil, MD, MPH, David A. Lindholm, MD, FACP, Richard A. Mularski, MD, MSHS, MCR, ATSF, FCCP, FACP, Justin R. Ortiz, MD, MS, FACP, FCCP, Victor Tapson, MD, C. Jason Liang, PhD, On behalf of the ACTT-1 Study Group, Aneesh K. Mehta, Nadine G. Rouphael, Jessica J. Traenkner, Valeria D Cantos, Ghina Alaaeddine, Barry S. Zingman, Robert Grossberg, Paul F. Riska, Elizabeth Hohmann, Mariam Torres-Soto, Nikolaus Jilg, Helen Y. Chu, Anna Wald, Margaret Green, Annie Luetkemeyer, Pierre-Cedric B. Crouch, Hannah Jang, Susan Kline, Joanne Billings, Brooke Noren, Diego Lopez de Castilla, Jason W. Van Winkle, Francis X. Riedo, Robert W. Finberg, Jennifer P. Wang, Mireya Wessolossky, Kerry Dierberg, Benjamin Eckhardt, Henry J Neumann, Victor Tapson, Jonathan Grein, Fayyaz Sutterwala, Lanny Hsieh, Alpesh N. Amin, Thomas F. Patterson, Heta Javeri, Trung Vu, Roger Paredes, Lourdes Mateu, Daniel A. Sweeney, Constance A. Benson, Farhana Ali, William R. Short, Pablo Tebas, Jessie Torgersen, Giota Touloumi, Vicky Gioukari, David Chien Lye, Sean WX Ong, Norio Ohmagari, Ayako Mikami, Gerd Fätkenheuer, Jakob J. Malin, Philipp Koehler, Andre C. Kalil, LuAnn Larson, Angela Hewlett, Mark G. Kortepeter, C. Buddy Creech, Isaac Thomsen, Todd W. Rice, Babafemi Taiwo, Karen Krueger, Stuart H. Cohen, George R. Thompson, 3rd, Cameron Wolfe, Emmanuel B. Walter, Maria Frank, Heather Young, Ann R. Falsey, Angela R. Branche, Paul Goepfert, Nathaniel Erdmann, Otto O. Yang, Jenny Ahn, Anna Goodman, Blair Merrick, Richard M. Novak, Andrea Wendrow, Henry Arguinchona, Christa Arguinchona, Sarah L. George, Janice Tennant, Robert L. Atmar, Hana M. El Sahly, Jennifer Whitaker, D. Ashley Price, Christopher J. A. Duncan, Simeon Metallidis, Theofilos Chrysanthidis, F. McLellan, Myoung-don Oh, Wan Beom Park, Eu Suk Kim, Jongtak Jung, Justin R. Ortiz, Karen L. Kotloff, Brian Angus, Jack David Germain Seymour, Noreen A. Hynes, Lauren M. Sauer, Neera Ahuja, Kari Nadeau, Patrick E. H. Jackson, Taison D. Bell, Anastasia Antoniadou, Konstantinos Protopapas, Richard T Davey, Jocelyn D. Voell, Jose Muñoz, Montserrat Roldan, Ioannis Kalomenidis, Spyros G. Zakynthinos, Catharine I. Paules, Fiona McGill, Jane Minton, Nikolaos Koulouris, Zafeiria Barmparessou, Edwin Swiatlo, Kyle Widmer, Nikhil Huprikar, Anuradha Ganesan, Guillermo M. Ruiz-Palacios, Alfredo Ponce de León, Sandra Rajme, Justino Regalado Pineda, José Arturo Martinez-Orozco, Mark Holodniy, Aarthi Chary, Timo Wolf, Christoph Stephan, Jan-Christian Wasmuth, Christoph Boesecke, Martin Llewelyn, Barbara Philips, Christopher J. Colombo, Rhonda E. Colombo, David A. Lindholm, Katrin Mende, Tida Lee, Tahaniyat Lalani, Ryan C. Maves, Gregory C. Utz, Jens Lundgren, Marie Helleberg, Jan Gerstoft, Thomas Benfield, Tomas Jensen, Birgitte Lindegaard, Lothar Weise, Lene Knudsen, Isik Johansen, Lone W Madsen, Lars Østergaard, Nina Stærke, Henrik Nielsen, Timothy H. Burgess, Michelle Green, Mat Makowski, Jennifer L. Ferreira, Michael R. Wierzbicki, Tyler Bonnett, Nikki Gettinger, Theresa Engel, Jing Wang, John H. Beigel, Kay M. Tomashek, Seema Nayak, Lori E. Dodd, Walla Dempsey, Effie Nomicos, Marina Lee, Peter Wolff, Rhonda PikaartTautges, Mohamed Elsafy, Robert Jurao, Hyung Koo, Michael Proschan, Dean Follmann, H. Clifford Lane
Publikováno v:
Critical Care Explorations, Vol 3, Iss 7, p e0474 (2021)
Crit Care Explor
Crit Care Explor
OBJECTIVES:. We sought to validate prognostic scores in coronavirus disease 2019 including National Early Warning Score, Modified Early Warning Score, and age-based modifications, and define their performance characteristics. DESIGN:. We analyzed pro
Autor:
Paolo Denti, John A. Joska, Gerda Wahl, Shiraz Moosa, John H. Black, Robert J. Wilkinson, Louise Lai Sai, Marise Bremer, Ernesta M. Meintjes, Graeme Meintjes, Sally Candy, Patryk Szymanski, Saalikha Aziz, Lori E. Dodd, Rene Goliath, Frances Robertson, Cari Stek, Ismail Banderker, Anna J. Dreyer, Sean Wasserman, Isak D Vorster, Amanda Jackson, Yakub E Kadernani, Sam Nightingale, Jonathan Naude, Angharad G Davis, Gary Maartens, Thomas Crede, C.Jason Liang, Peter J Raubenheimer, Remy Daroowala, Yakoob Vallie, Mpumi Maxebengula, Rachel P. J. Lai, Stephani Stegmann, Sonya Koekemoer, Thandi Sihoyiya, Curtis Offiah
Publikováno v:
Wellcome Open Research
Background: Tuberculous meningitis (TBM) is the most lethal form of tuberculosis with a mortality of ~50% in those co-infected with HIV-1. Current antibiotic regimens are based on those known to be effective in pulmonary TB and do not account for the
Autor:
Virginia Sheikh, Silvia Lucena Lage, Elizabeth Laidlaw, Afroditi Boulougoura, Corina Millo, Jing Wang, Irini Sereti, Adam Rupert, Dorinda Metzger, Georgios Z. Papadakis, Dima A. Hammoud, Lori E. Dodd, Andrea Lisco, Gregg Roby, JoAnn M. Mican, Jeanette Higgins, Chun-Shu Wong, Maura Manion, Alice Pau
Publikováno v:
Clinical Infectious Diseases. 68:229-238
BACKGROUND: Immune reconstitution inflammatory syndrome (IRIS) represents an unexpected inflammatory response shortly after initiation of antiretroviral therapy (ART) in some human immunodeficiency virus (HIV)–infected patients with underlying neop
Publikováno v:
Annals of Internal Medicine. 174:730-731
Publikováno v:
The New England Journal of Medicine
Caution in Interpreting Platform Trials Multiplatform trials in which experimental groups are allowed to enter and exit the trial at different times often include a single control group in which re...